David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Alexandre EUSEBIO, Praticien Hospitalier Universitaire, MD, PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Service de neurologie, pathologie du mouvement

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

Laurent ZIELESKIEWICZ, PhD, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM, Service d'anesthésie réanimation

David LAGIER, MD PhD, Assistance Publique Hôpitaux de Marseille, Marseille, APHM

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

PDF) X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. - Abstract - Europe PMC